Endocrinology, Diabetes & Metabolism

The Role and Mechanism of Incretins in Gynaecologic Diseases

By Jiayu Yan, Minyue Cao, Yan Ding, Bilan Li

Abstract

Background Obesity is a major global public health concern closely linked to the development and progression of various gynaecological disorders, particularly polycystic ovary syndrome (PCOS) and endometrial cancer.

GLP-1 receptor agonists
AMPK signalling
cAMP signalling
Endometrial cancer
Endometriosis
Humans

The paper

Jiayu Yan, Minyue Cao, Yan Ding, Bilan Li

Tongji University

Endocrinology, Diabetes & Metabolism, 1 Sep 2026, CC BY

doi.org/10.1002/edm2.70340 PubMed 42789930

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity

The Role and Mechanism of Incretins in Gynaecologic Diseases

Abstract

The paper

More on GLP-1 receptor agonists

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk

GLP-1 receptor agonists link to lower stroke and Alzheimer risk

Survodutide reduces weight in adults with diabetes and obesity

Retatrutide reduces weight and pain in adults with obesity